Wells Fargo & Company (WFC)

Wells Fargo & Company (WFC) trades at $85.80 as of November 11, 2026, above its 20-day, 50-day and 200-day averages, and the stock sits about midway through its 52-week range. The main tension is between a cheap valuation and a slower top line. The stock trades at a 12.10 trailing P/E against a sector median of 16.5, and analysts' median 12-month target is $97.50. Revenue grew 9.98% in the latest quarter, a little slower than the sector median of 11.7%. Recent news is mostly rating reiterations after the October 13, 2026 earnings report, when the EPS beat was small and the shares fell 3.10% in the next session.

At a trailing P/E of 12.10, the stock trades at a discount to peers, against a sector median of 16.5. The price-to-sales ratio of 3.10 is also below the sector median of 3.8. Earnings per share over the last 12 months were $7.09 on a reported basis. This is the clearest reason the valuation factor scores so strongly in the CleaRank rating.

The October 13, 2026 report beat by a narrow 0.54%, with adjusted EPS of $1.87 against an estimate of $1.86, and the shares fell 3.10% in the first session after it. The July 14, 2026 report was a larger beat, with EPS of $2.00 against $1.72, yet the stock also fell 2.71% that session. Across the last eight reports, the share price was lower in the first session after six of them, and higher after two. Beats have therefore not translated into gains on the day, and investors appear to be focused on what comes after the headline numbers.

The stock is 1.73% above its 50-day average and 2.76% above its 200-day average, and the 50-day average is 1.01% above the 200-day average. The 14-day RSI of 55.9 is in the neutral zone, and the MACD line is positive. The one-month gain of 2.98% sits against a three-month decline of 3.52%, so the recent direction is up but the longer picture is flat.

Of 27 analysts with a current rating, 18 rate the stock buy or strong buy and 9 rate it hold, with none at sell. Three months ago, 16 of 26 ratings were buy. The median 12-month target is $97.50, with a range from $88.00 to $108.00. In the October 2026 round, JP Morgan and Citigroup kept neutral ratings, Keefe, Bruyette & Woods kept a market perform rating, Morgan Stanley kept an overweight rating and RBC Capital kept an outperform rating, while TD Cowen restarted coverage at Buy on October 8, 2026. Insiders sold $7.9M of stock across two sales over the last 18 months and made no open-market purchases. Those sales may have been planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would.

The base case is that the stock keeps trading in its current range while the earnings path does the work. Analysts expect EPS to rise 17.3% this fiscal year, to $7.34, and a further 9.7% to $8.06 next fiscal year, so the valuation discount has a stated earnings base behind it. For the shares to move toward the analysts' median target of $97.50, the next reports would need to show revenue growth closer to the sector median and an EPS beat that holds through the first trading session. The lowest target of $88.00 sits just above the current price. A weaker revenue line, or another earnings reaction like the 3.10% drop after October 13, would push the stock back toward its moving averages and weaken the case for the discount to narrow.

Support sits first at the 20-day exponential moving average of $84.39, then the 50-day simple moving average at $84.34, and the 200-day simple moving average at $83.50. These three averages cluster close together, so a break below them would likely be read as a loss of the short-term trend. Further down, the 52-week low of $72.78 is the level a fall would meet next. Resistance sits at the 52-week high of $97.76, which the stock would need to clear to set new highs for the year.